1 – 100 of 2187
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Clinical Implications of Discrepancy between One-stage Clotting and Chromogenic Factor IX Activity in Haemophilia B
(
- Contribution to journal › Article
-
Mark
Single-cell analysis of immune recognition in chronic myeloid leukemia patients following tyrosine kinase inhibitor discontinuation
(
- Contribution to journal › Article
-
Mark
Indirect treatment comparison of brexucabtagene autoleucel (ZUMA-2) versus standard of care (SCHOLAR-2) in relapsed/refractory mantle cell lymphoma
(
- Contribution to journal › Article
-
Mark
Treatment outcomes of childhood PICALM::MLLT10 acute leukaemias
(
- Contribution to journal › Article
-
Mark
Health-related quality of life and physical activity in Nordic patients with moderate haemophilia A and B (the MoHem study)
(
- Contribution to journal › Article
-
Mark
Red blood cell-derived arginase release in hemolytic uremic syndrome
(
- Contribution to journal › Article
-
Mark
Prophylactic Treatment of Children with Hemophilia in Sweden
(
- Contribution to journal › Scientific review
-
Mark
Haemophilia A - In pursuit of optimised outcomes via personalised treatment
2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Etranacogene dezaparvovec gene therapy for haemophilia B (HOPE-B) : 24-month post-hoc efficacy and safety data from a single-arm, multicentre, phase 3 trial
2024) In The Lancet Haematology(
- Contribution to journal › Article
-
Mark
Elucidating the Blood Group Regulome
2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Ontogeny shapes the ability of ETV6::RUNX1 to enhance hematopoietic stem cell self-renewal and disrupt early lymphopoiesis
(
- Contribution to journal › Letter
-
Mark
Recombinant factor IX Fc for the treatment of hemophilia B
(
- Contribution to journal › Scientific review
-
Mark
LIN28B promotes differentiation of fully transformed AML cells but is dispensable for fetal leukemia suppression
(
- Contribution to journal › Letter
-
Mark
International Prophylaxis Study Group (IPSG) haemophilia joint MRI scale version 2.0
(
- Contribution to journal › Letter
-
Mark
Origin of pathogenic variant and mosaicism in families with a sporadic case of haemophilia B
2024) In Haemophilia(
- Contribution to journal › Article
-
Mark
A Bioinformatically Initiated Approach to Evaluate GATA1 Regulatory Regions in Samples with Weak D, Del, or D- Phenotypes Despite Normal RHD Exons
2024) In Transfusion Medicine and Hemotherapy(
- Contribution to journal › Article
-
Mark
Evidence that CD36 is expressed on red blood cells and constitutes a novel blood group system of clinical importance
(
- Contribution to journal › Article
-
Mark
Genome-wide CRISPR/Cas9 screen identifies regulators of BCMA expression on multiple myeloma cells
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Factors affecting prognosis of MGUS and multiple myeloma
2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Akkermansia muciniphila exoglycosidases target extended blood group antigens to generate ABO-universal blood
2024) In Nature Microbiology(
- Contribution to journal › Article
-
Mark
A machine-learning method for biobank-scale genetic prediction of blood group antigens
(
- Contribution to journal › Article
-
Mark
Population scale proteomics enables adaptive digital twin modelling in sepsis
2024)(
- Working paper/Preprint › Preprint in preprint archive
-
Mark
Decreased neutrophil function in newly diagnosed multiple myeloma patients is restored with lenalidomide therapy
2024) In European Journal of Haematology(
- Contribution to journal › Article
-
Mark
Primary prophylaxis implementation and long-term joint outcomes in Swedish haemophilia A patients
2024) In Haemophilia(
- Contribution to journal › Article
-
Mark
A complex interplay of intra- and extracellular factors regulates the outcome of fetal- and adult-derived MLL-rearranged leukemia
2024) In Leukemia(
- Contribution to journal › Article
-
Mark
Postnatal origin of the chromosomal gains in older patients with high hyperdiploid acute lymphoblastic leukemia
(
- Contribution to journal › Letter
-
Mark
Cytarabine dose intensification improves survival in older patients with secondary/high-risk acute myeloid leukemia in matched real-world versus clinical trial data
2024) In Leukemia and Lymphoma(
- Contribution to journal › Article
-
Mark
Sicklecellsjukdom - vanliga och farliga komplikationer
(
- Contribution to journal › Article
-
Mark
Bleeding phenotype according to factor level in 825 children with nonsevere hemophilia : data from the PedNet cohort
2024) In Journal of Thrombosis and Haemostasis(
- Contribution to journal › Article
-
Mark
Reduced Intensity transplantation vs chemotherapy in CR1. A prospective, pseudorandomized study in 50–70 year old AML patients
(
- Contribution to journal › Article
-
Mark
Oesophageal Lichen Planus Successfully Treated with Budesonide Orodispersible Tablets : A Case Report
(
- Contribution to journal › Article
-
Mark
A temporal developmental map separates human NK cells from noncytotoxic ILCs through clonal and single-cell analysis
(
- Contribution to journal › Article
-
Mark
Low bleeding rates after intramuscular Covid-19 vaccination in patients with haemophilia and von Willebrand disease : Outcome data from the Swedish haemophilia registry
2024) In Haemophilia(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Large differencies in age-specific survival in multiple myeloma in the nordic countries
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Age-specific survival in acute myeloid leukemia in the Nordic countries through a half century
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Empowering macrophages : the cancer fighters within the tumour microenvironment in mantle cell lymphoma
(
- Contribution to journal › Article
-
Mark
How to manage patients with germline DDX41 variants : Recommendations from the Nordic working group on germline predisposition for myeloid neoplasms
(
- Contribution to journal › Article
- 2023
-
Mark
Sexual function of adult long-term survivors and their partners after allogeneic hematopoietic cell transplantation in Europe (S-FAST) : a study from the Transplant Complications Working Party and Nurses Group of the EBMT
(
- Contribution to journal › Article
-
Mark
Severe, life-threatening, and fatal chronic health conditions after allogeneic blood or marrow transplantation in childhood
(
- Contribution to journal › Article
-
Mark
Acquired Haemophilia A in four north European countries : survey of 181 patients
(
- Contribution to journal › Article
-
Mark
Multiparameter flow cytometry in the evaluation of myelodysplasia : Analytical issues: Recommendations from the European LeukemiaNet/International Myelodysplastic Syndrome Flow Cytometry Working Group
(
- Contribution to journal › Scientific review
-
Mark
Real-world prophylactic usage of recombinant factor IX Fc in Sweden : A report from the Swedish National Registry for bleeding disorders
(
- Contribution to journal › Letter
-
Mark
Multicenter prospective evaluation of diagnostic potential of flow cytometric aberrancies in myelodysplastic syndromes by the ELN iMDS flow working group
(
- Contribution to journal › Article
-
Mark
Area under the curve : Comparing the value of factor VIII replacement therapies in haemophilia A
(
- Contribution to journal › Article
-
Mark
BAY 81-8973 Efficacy and Safety in Previously Untreated and Minimally Treated Children with Severe Hemophilia A : The LEOPOLD Kids Trial
(
- Contribution to journal › Article
-
Mark
Prophylaxis use of clotting factor replacement products in people with non-severe haemophilia : A review of the literature
(
- Contribution to journal › Scientific review
-
Mark
The complement receptor C3AR constitutes a novel therapeutic target in NPM1-mutated AML
(
- Contribution to journal › Article
-
Mark
A novel GYP(B-A-B) hybrid in a blood donor identified by a phenotyping discrepancy with different anti-s reagents
(
- Contribution to journal › Article
-
Mark
No difference in quality of life between persons with severe haemophilia A and B
(
- Contribution to journal › Article
-
Mark
A Receptor Tyrosine Kinase Inhibitor Sensitivity Prediction Model Identifies AXL Dependency in Leukemia
(
- Contribution to journal › Article
-
Mark
Overexpression of the key metabolic protein CPT1A defines mantle cell lymphoma patients with poor response to standard high dose chemotherapy independent of MIPI and complement established high-risk factors
(
- Contribution to journal › Article
-
Mark
The International Consensus Classification of acute myeloid leukemia
(
- Contribution to journal › Scientific review
-
Mark
Applicability of the European Society of Cardiology Guidelines on the management of acute coronary syndromes to older people with haemophilia A – A modified Delphi consensus by the ADVANCE Working Group
(
- Contribution to journal › Scientific review
-
Mark
Real-world experience among patients with relapsed/refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor failure in Europe : The SCHOLAR-2 retrospective chart review study
(
- Contribution to journal › Article
-
Mark
Complement activation negatively affects the platelet response to thrombopoietin receptor agonists in patients with immune thrombocytopenia: : a prospective cohort study
(
- Contribution to journal › Article
-
Mark
Late effects in patients with mantle cell lymphoma treated with or without autologous stem cell transplantation
(
- Contribution to journal › Article
-
Mark
Neutrophils as Suppressor Cells and their role in Multiple Myeloma
2023) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Koagulationsfaktor XIII – inte bara ett kongenitalt blödningsproblem
(
- Contribution to journal › Scientific review
-
Mark
Spatially Guided and Single Cell Tools to Map the Microenvironment in Cutaneous T-Cell Lymphoma
(
- Contribution to journal › Article
-
Mark
Characterization of therapy-related acute myeloid leukemia : increasing incidence and prognostic implications
(
- Contribution to journal › Article
-
Mark
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B
(
- Contribution to journal › Article
-
Mark
Haemophilia B - Diagnostic Insights, Genetic Aspects and Clinical Outcomes
2023) In Lund University, Faculty of Medicine, Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Temporal dynamics of TNF-mediated changes in hematopoietic stem cell function and recovery
(
- Contribution to journal › Article
-
Mark
Intracranial Hemorrhages in Neonates : Incidence, Risk Factors and Treatment
(
- Contribution to journal › Article
-
Mark
A large cohort study of the effects of Lewis, ABO, 13 other blood groups, and secretor status on COVID-19 susceptibility, severity, and long COVID-19
(
- Contribution to journal › Article
-
Mark
Contribution of rare and common coding variants to haematological malignancies in the UK biobank
(
- Contribution to journal › Article
-
Mark
F8/F9 variants in the population-based PedNet Registry cohort compared with locus-specific genetic databases of the European Association for Haemophilia and Allied Disorders and the Centers for Disease Control and Prevention Hemophilia A or Hemophilia B Mutation Project.
(
- Contribution to journal › Article
-
Mark
A fetal tumor suppressor axis abrogates MLL-fusion-driven acute myeloid leukemia
(
- Contribution to journal › Article
-
Mark
Methods for anti-factor VIII antibody levels in haemophilia A patients-validation of a multiplec immunoassay and comparability with assays measuring non-neutralising and neutralising antibodies (inhibitors)
(
- Contribution to journal › Article
-
Mark
Enhanced protein synthesis is a defining requirement for neonatal B cell development
2023) In Frontiers in Immunology(
- Contribution to journal › Article
-
Mark
Validation of immunofluorescence analysis of blood smears in patients with inherited platelet disorders
(
- Contribution to journal › Article
-
Mark
ABO Genotyping finds more A2 to B kidney transplant opportunities than lectin-based subtyping
(
- Contribution to journal › Article
-
Mark
Binge-reading on immune thrombocytopenia : Everything you ever wanted to know
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
IRF1 regulates self-renewal and stress-responsiveness to support hematopoietic stem cell maintenance
2023)(
- Working paper/Preprint › Preprint in preprint archive
-
Mark
An HPA-1a–positive platelet–depleting agent for prevention of fetal and neonatal alloimmune thrombocytopenia : a randomized, single-blind, placebo–controlled, single-center, phase 1/2 proof-of-concept study
(
- Contribution to journal › Article
-
Mark
Considerations for shared decision management in previously untreated patients with hemophilia A or B
(
- Contribution to journal › Scientific review
-
Mark
HLA Class I Genotype Is Associated with Relapse Risk after Allogeneic Stem Cell Transplantation for NPM1-Mutated Acute Myeloid Leukemia
(
- Contribution to journal › Article
-
Mark
IL1RAP is expressed in several subtypes of pediatric acute lymphoblastic leukemia and can be used as a target to eliminate
ETV6::RUNX1-positive leukemia cells in preclinical models.
(
- Contribution to journal › Article
-
Mark
A novel nonsense variant in RHAG underlies a Nordic Rhnull phenotype.
(
- Contribution to journal › Article
-
Mark
Babesia divergens Shows Equal Predilection for Human ABO Blood Types in an In Vitro Erythrocyte Preference Assay.
(
- Contribution to journal › Article
-
Mark
The LW blood group system : not just "tagging along" with D
(
- Contribution to journal › Scientific review
-
Mark
Immune tolerance induction in development
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
TEMRA : the CD8 subset in chronic ITP?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Genetic Subtypes and Outcome of Patients Aged 1 to 45 Years Old with Acute Lymphoblastic Leukemia in the NOPHO ALL2008 Trial
(
- Contribution to journal › Article
-
Mark
The IgG-degrading enzyme, Imlifidase, restores the therapeutic activity of FVIII in inhibitor-positive hemophilia A mice
(
- Contribution to journal › Article
-
Mark
Exploring new prognostic biomarkers in Mantle Cell Lymphoma : a comparison of the circSCORE and the MCL35 score
(
- Contribution to journal › Article
-
Mark
Impact of timing of prophylaxis commencement, F8 genotype and age on factor consumption and health-related quality of life in patients with severe haemophilia A
(
- Contribution to journal › Article
-
Mark
Challenging the definition of a blood group: Proposal to make CD36 a novel blood group system based on a case report and pre-existing genetic, proteomic and clinical data
(
- Contribution to journal › Published meeting abstract
-
Mark
Elucidation of the low-expressing erythroid CR1 phenotype by bioinformatic mining of the GATA1-driven blood-group regulome
(
- Contribution to journal › Article
-
Mark
Pirtobrutinib targets BTK C481S in ibrutinib-resistant CLL but second-site BTK mutations lead to resistance
(
- Contribution to journal › Article
-
Mark
Nationwide Assessment of Patient Trajectories in Mantle Cell Lymphoma : The Swedish MCL complete Project
(
- Contribution to journal › Article
-
Mark
Novel precision medicine approaches and treatment strategies in hematological malignancies
(
- Contribution to journal › Scientific review
-
Mark
An ultra-rapid screening method for acute leukemias
(
- Contribution to journal › Article
-
Mark
Report on 4 cases with decreased recovery due to neutralizing antibodies specific for PEGylated recombinant factor VIII
(
- Contribution to journal › Article
-
Mark
Dilemmas on emicizumab in children with haemophilia A : A survey of strategies from PedNet centres
(
- Contribution to journal › Article
-
Mark
Genetic prediction of 33 blood group phenotypes using an existing genotype dataset
(
- Contribution to journal › Article
-
Mark
Desialylated Platelet Clearance in the Liver is a Novel Mechanism of Systemic Immunosuppression
(
- Contribution to journal › Article
-
Mark
Infrastructural considerations of implementing gene therapy for hemophilia in the Nordic context
(
- Contribution to journal › Article
-
Mark
Recombinant factor IX Fc prophylaxis reduces pain and increases levels of physical activity, with sustained, long-term improvements in patients with hemophilia B : post hoc analysis of phase III trials using patient-reported outcomes
(
- Contribution to journal › Article
-
Mark
Transfusion management in the era of magrolimab (Hu5F9-G4), an anti-CD47 monoclonal antibody therapy
(
- Contribution to journal › Scientific review